AbbVie Inc.
ABBV · scored from FY2025 filings · Shallow moat
Doesn't clear the bar
The four filters
Pricing power95
Median gross margin 70.1% over 10y, very stable.
Returns on capital89
Median ROIC 17.5%, above the 9% hurdle in 100% of years.
Balance-sheet safety8
Net debt/EBITDA 4.1x, interest coverage 5x.
Capital discipline10
Owner earnings -6.4%/yr, share count growing (dilution).
Margin of safety
Above valueOn sale
- Owner earnings (normalized)
- $4.1B
- Est. intrinsic value / share
- $24.69
- Recent price
- —
- Discount to value
- No price data
Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).
Moat Score history
Scores are logged append-only and never overwritten — this record can't be backfilled, which is exactly why it's worth keeping.